Kentucky Retirement Systems Has $2.29 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Kentucky Retirement Systems trimmed its position in Agilent Technologies, Inc. (NYSE:AFree Report) by 2.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,607 shares of the medical research company’s stock after selling 442 shares during the quarter. Kentucky Retirement Systems’ holdings in Agilent Technologies were worth $2,294,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Flynn Zito Capital Management LLC increased its position in Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock worth $251,000 after purchasing an additional 69 shares in the last quarter. IFP Advisors Inc grew its stake in shares of Agilent Technologies by 17.7% during the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock worth $62,000 after buying an additional 69 shares during the last quarter. Tiemann Investment Advisors LLC increased its holdings in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock worth $191,000 after buying an additional 75 shares in the last quarter. Rothschild Investment LLC lifted its stake in shares of Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after acquiring an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC boosted its holdings in shares of Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock valued at $1,025,000 after acquiring an additional 87 shares in the last quarter. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A has been the topic of several recent research reports. Barclays cut their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a research note on Thursday, May 29th. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a report on Monday, April 21st. UBS Group reduced their price target on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research report on Thursday, May 29th. Finally, Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, June 14th. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $140.15.

View Our Latest Report on A

Agilent Technologies Trading Up 0.6%

A opened at $116.21 on Tuesday. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The firm has a market capitalization of $33.01 billion, a PE ratio of 28.69, a P/E/G ratio of 3.51 and a beta of 1.23. The company’s 50-day moving average is $110.89 and its 200 day moving average is $124.33.

Agilent Technologies (NYSE:AGet Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. Agilent Technologies’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.22 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies’s payout ratio is 24.44%.

Insider Activity at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the firm’s stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at $4,161,931.02. This trade represents a 4.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.26% of the stock is currently owned by company insiders.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.